News | December 05, 2021
Monthly production capacity of Covishield and Covaxin touches 90% : Govt
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
The recommendation was made by the Indian SARS-CoV-2 Genomics Sequencing Consortium (INSACOG), a network of national testing labs set up by the government to monitor genomic variations of Covid-19
The product will be commercialized from Unichem's Ghaziabad plant
This further adds to Biocon’s portfolio of vertically integrated complex drug products
Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry
The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on August 20
One of the very few facilities in India to have this capability, marking a remarkable feat in LifeCell’s expedition to take genome sequencing to the next level in India
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
Subscribe To Our Newsletter & Stay Updated
